GRAS for Roche Omega-3 ingredient
Roche Vitamins has announced that its omega-3 product, ROPUFA '75', has gained GRAS self-affirmation in the United States, allowing it to be used in fortified foods.
Archives for April 22, 2003
Ironing out nutrient deficiencies
A collaboration between US scientists and a Nigerian agriculture agency may have found a way of reducing iron deficiency in western Africa without resorting to more expensive fortification programmes.
New role for gelatine?
Researchers find that the ingredient gelatine stimulates collagen synthesis in cartilage cells and may be able to treat arthritis, reports gelatine producer DGF STOESS.
Tea shown to fight infection
Drinking tea appears to prime the immune system to fight infection and chronic disease, according to US researchers, who report on both laboratory and in vivo studies this week.
Sales sweet for Corn Products
Sales for US food ingredients company Corn Products International were on target for the first quarter of 2003 ended 31 March 2003 with the company announcing on Tuesday that sales had risen 23 per cent, lifting earnings and increasing the operating...
Roche gains GRAS for Omega-3 ingredient
Roche Vitamins has announced that its omega-3 product, ROPUFA '75', has gained GRAS self-affirmation, allowing it to be used in fortified foods.
Aventis sells Rhodia stake
Franco-German pharmaceuticals company Aventis continues the divestment of French speciality chemicals company Rhodia with the announcement on Tuesday that it has reduced its stake from 25.2 per cent to 15.3 per cent by selling 17.8 million of Rhodia...
Gelatine boosts collagen synthesis
Can gelatine play a role in preventing and treating degenerative arthritic disease? New research from Germany supports previous evidence and suggests that gelatine could stimulate collagen synthesis in cartilage cells.
WHO report defies sugar industry attack
The UN Food and Agriculture Organization (FAO) and the World Health Organization (WHO) release their controversial report on diet and its impact on disease in Rome today, despite severe lobbying from the US Sugar Association.